Effect of Low-glycemic Index Meals Intake on DM2 Women Under Metformin Therapy

Effect of Low-glycemic Index Lunches and Dinners Intake on Indicators of Satiety, Metabolic Parameters and Liver Steatosis Degree on Women With Type 2 Diabetes Under Metformin Therapy: Controlled Clinical Trial

To compare the effect of low-glycemic index versus control lunches and dinners intake on indicators of satiety, metabolic parameters and liver steatosis degree on women with type 2 diabetes under metformin therapy.

Inclusion Criteria:

• Subjets with type 2 diabetes mellitus diagnosis under metformin therapy.
• Female sex.
• Aged 30 to 65 years.
• Body Mass Index (BMI) 22 to 34.9 kg / m2.

Exclusion Criteria:

• Women with insulin-releasing drugs or insulin treatment.
• Patients with diabetic nephropathy, retinopathy, chronic kidney disease, stroke.
• Subjects with hypothyroidism without treatment.
• Individuals with food allergies or intolerances.
• Women who present an intake of ≥20 g of alcohol per day quantified through a closed consumption frequency survey.
• Patients with previously diagnosed hepatitis, hepatic cirrhosis or liver cancer.